Figure 2
From: Pediatric T- and NK-cell lymphomas: new biologic insights and treatment strategies
Time and site of disease recurrence in children with relapsed lymphoblastic lymphoma. I, patients with T-LBL; X, patients with precursor B-cell lymphoblastic lymphoma; BM, bone marrow. (*) Patient was treated on a high-risk arm and experienced relapse during an intensive phase of treatment 11 months after start of therapy. Reprinted from Burkhardtet al.10
